Nanoparticles for Glioblastoma Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 1448
Editors
Interests: nanoparticles; biomaterials; gene delivery; glioblastoma; cancer stem cells; blood–brain barrier
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; peptide and protein chemistry; antibody engineering; blood–brain barrier
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Glioblastoma (GBM) remains a formidable challenge with limited therapeutic options and poor prognosis. Nanoparticle-based drug delivery systems offer a promising avenue to overcome obstacles in GBM treatment, including the blood–brain barrier (BBB) and tumor heterogeneity.
This Special Issue highlights the potential of nanoparticles for enhancing GBM therapy. We invite contributions exploring how nanoparticles can be engineered to improve drug penetration across the BBB, selectively target tumor cells, and enable controlled drug release. We also welcome submissions on various nanoparticle types, including lipid-based, polymeric, and inorganic nanoparticles, and their application in delivering chemotherapeutic agents, gene therapies, and other therapeutic modalities.
Furthermore, we encourage submissions presenting preclinical studies that demonstrate the ability of nanoparticles to enhance GBM treatment efficacy by increasing drug concentration at the tumor site, reducing systemic toxicity, and overcoming drug resistance mechanisms. Submissions focusing on functionalized nanoparticles with specific ligands or antibodies for active GBM cell targeting are also highly encouraged. This Special Issue aims to gather cutting-edge research that will advance the translation of these promising findings into clinical applications and ultimately improve the survival and quality of life of individuals with GBM.
The Special Issue of Pharmaceutics invites submissions related to drug delivery systems, innovative formulations, nanomedicine, and targeted therapy. The Special Issue of Biomedicines encourages contributions centered on biological aspects.
You may choose our Joint Special Issue in Biomedicines.
Dr. Shambhavi Pandey
Dr. Benjamí Oller-Salvia
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- blood–brain barrier
- gene delivery
- glioblastoma
- cancer stem cells
- biomaterials
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
